ERX Eirx Therap.

RNS Number:5114O
EiRx Therapeutics PLC
21 February 2008


TR-1: Notifications of Major Interests in Shares


                                                              
1. Identity of the issuer or the underlying issuer of
existing shares to which voting rights are attached:

Eirx Therapeutics Plc


2. Reason for notification (yes/no)
                                                                                        

An acquisition or disposal of voting rights                               YES
                                                                                        

An acquisition or disposal of financial instruments which may result in the
acquisition of shares already issued to which voting rights are attached    NO
                                                                                        

An event changing the breakdown of voting rights                            NO
                                                                                        

Other (please specify):______________                                       NO


3. Full name of person(s) subject to notification                      
obligation:

Barclays PLC


4. Full name of shareholder(s) (if different from               
3):

Barclays Stockbrokers Ltd


5. Date of transaction (and date on which the                        
threshold is crossed or reached if different):

19 February 2008

6. Date on which issuer notified:                                    

20 February 2008


7. Threshold(s) that is/are crossed or reached:                          

6% to 7%


8. Notified details:                                                       

N/A



A: Voting rights attached to shares


Class/type of   Situation previous to the Resulting situation after the triggering transaction
shares          triggering transaction
                Number of    Number of    Number of     Number of voting rights  Percentage of voting
If possible use shares       voting       shares                                 rights
ISIN code                    rights

                                          Direct        Direct      Indirect     Direct      Indirect

GB00B0XQBS97    187,968,924  187,968,924  211,630,528   0           211,630,528  0.00        7.11


B: Financial Instruments


Resulting situation after the triggering transaction


Type of financial    Expiration date      Exercise/ conversion No. of voting rights  Percentage of voting
instrument                                period/date          that may be acquired  rights
                                                               (if the instrument
                                                               exercised/converted)

N/A                  N/A                  N/A                  N/A                   N/A


Total (A+B)
Number of voting rights                              Percentage of voting rights

 211,630,528                                         7.11


9. Chain of controlled undertakings through which the voting rights and /or the
financial instruments are effectively held, if applicable:


Barclays Stockbrokers Ltd






Proxy Voting:


10. Name of proxy holder:                                 N/A


11. Number of voting rights proxy holder will cease       N/A
to hold:


12. Date on which proxy holder will cease to hold         N/A
voting rights:




13. Additional information:                               N/A



14 Contact name:                                       Geoff Smith


15. Contact telephone name:                            0207 116 2913





For notes on how to complete form TR-1 please see the FSA website.



                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

HOLUAUNRWSRUUAR

Eirx Therapeutics (LSE:ERX)
Historical Stock Chart
From May 2024 to Jun 2024

Eirx Therapeutics (LSE:ERX)
Historical Stock Chart
From Jun 2023 to Jun 2024